Dario Amodei Watch posted an update
At Anthropic’s Nasdaq debut, Dario Amodei spoke about his father, whose illness helped draw him towards biology and AI, Open Magazine writes. The personal account put a human question alongside the IPO’s billion-dollar figures: could AI help researchers find treatments sooner?
Why it mattersThe article says Amodei referred to the possibility of curing the disease that killed his father, and connects that hope to Anthropic’s work with researchers. It cites The Guardian’s live coverage for the remarks. That is a statement of ambition, not evidence that Claude has shortened drug-discovery timelines or produced a treatment. But it makes the test of AI for science unusually plain: what work gets done sooner, and does that change outcomes for patients?
Discuss: What evidence would convince you that AI is genuinely speeding up medical research, rather than simply adding another tool to the lab?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.